The Dealy Strategy Group LLC Presentation to Health TechNet

Slides:



Advertisements
Similar presentations
CTI LIFE SCIENCES FUND Role of a VC in Helping Commercialize Early Stage Innovation November 19 th 2007 Presented by: Richard J. Meadows Managing Partner.
Advertisements

Most investors have had limited exposure to the commodity, agricultural, food, and green energy (CAFÉ) sectors. MacroGain Partners has built a team to.
Shaking the MoneyTree™
1 EMERGING ENERGY & ENVIRONMENT, LLC TOWARDS A LOW CARBON ECONOMY: THE ROLE OF PRIVATE EQUITY FUNDS BY: JOHN PAUL MOSCARELLA Emerging Energy & Environment,
Module 4 The Search for Capital. Module 4 Topics Sources of Capital Background Start-up Ongoing Operations Growth.
1 Global Software II, 31January - 5 February 2002.
Global Software II Introduction Paving the Way to the US Market For Finnish Software Companies Copyright Global Software II 2002.
A Quick Overview of the VC Industry Ann Winblad, Partner Hummer Winblad Venture Partners
Entrepreneurship I Class #3 Financing the Venture.
Private Equity Fund Structure - Best Practices June 24 th, 2014.
Agenda Development phases of a company Venture capital characteristics
Jennifer H. Moore, Ph.D. Executive Director Southeast Region Technology Transfer Directors Meeting July 30, 2010.
KICKSTART SEED FUND: IGNITING INNOVATION KICKSTART SEED FUND OVERVIEW GAVIN CHRISTENSEN, MANAGING DIRECTOR, KICKSTART SEED FUND Aug, 2009.
VENTURE CAPITAL IMPORTANT SOURCE OF EQUITY FOR HIGH GROWTH COMPANIES.
Pharmaceutical Industry Emerging Opportunities for Mobile Health TechNet Meeting June 2005.
Vcapital Confidential1 Startup Workshop Presentation to.
”We aim to be the preferred life sciences investment company in Northern Europe…” “We have the people, the differentiation, the mind-set, and the structure.
Venture and Growth Capital. Equity Investments  Holding on to ‘what you’ve got’  Equity investments are a ‘trade-off’ game…
Compaq Computer Corporate Venture Capital March 3, 2001.
Global Venture Capital March 19, 2007 Michael Korver, Managing Partner.
Entrepreneurship in Missouri  Business Recruitment  Business Expansion  Entrepreneurism/New Business Formation Strategies for Economic Development.
Technology sector investment opportunities in the Baltics Private equity investor’s view Vygandas Juras Partner BaltCap Management.
Accelerating the development of world-class Irish companies to achieve strong positions in global markets resulting in increased national and regional.
Invest NI Access to Finance February Growth Loan Fund (£50m) (DEBT/MEZZ) Development Fund I (£30m) (EQUITY) Small Business Loan Fund (£5m) (DEBT)
1 Evolution and opportunities in the Greek capital market May 2001 Dr Panayotis Alexakis President of the Athens Stock Exchange (ASE) and the Athens Derivatives.
The State of Venture Investing and Observations on the Industry June 6, 2013 Mark G. Heesen NVCA President.
Employment Trends and Cluster Opportunities Presented to the Steering Committee for the Los Angeles and Orange County Regional Consortium November 14,
Funding a start-up: How to raise your first round Jayan Ramankutty Founder/CEO YuMe Networks BITSAA.org, June 25 th 2006.
Life Science Venture Capital 11th Annual NIH SBIR/STTR Conference July 1, 2009 Randy H. Weiss, Ph.D. Partner, Triathlon Medical Ventures.
Investing in the State of Innovation International Seminar on Knowledge and Innovation 1 October, 2013 Creating a High-Performance Innovation Ecosystem:
Venture Capital and the Finance of Innovation [Course number] Professor [Name ] [School Name] Chapter 1 The VC Industry.
# MCL 0 Today’s Venture Capital Environment Ted R. Woolschlager Director, Emerging Growth Markets Mid-Atlantic Area Ernst & Young June.
VED S.A.. VED Your trusted partner for Investment Management, Mergers & Acquisitions and Real Estate Investments VED S.A. 1.
HealthStart India Mr. Pradeep K. Jaisingh Chairman & Founder Enabling Healthcare Entrepreneurship.
National Holding & Emirates International Investment Company Charting a Sustainable Roadmap with Strategic Partnerships.
The State of Venture Capital March 2, 2002 John Gabbert Sr. Director, Worldwide Research VentureOne Corporation.
© 2007 Thomson South-Western Chapter 26 Entrepreneurial Finance And Venture Capital Professor XXXXX Course Name / Number.
Finance: Review of Ch What is Finance? 1.2 The Role of the Financial Manager 1.3 Who is the Financial Manager 1.4 Goal of the Firm ? 1.5 Agency Problem.
Private Sector / Angel Funding for Entrepreneurial Ventures Cybersecurity – Unmanned Systems Conference Jean Peters Board Member ACA Managing Director.
The 3 rd Annual Life Science Conference February 2001 Batsheva Elran - Concord Ventures.
Venture Healthcare – Industry Update JLABS Presentation December Jon Norris, Managing Director, SVB.
The Role of the Corporate Financial Advisor in Growth Financing and Public-Private Partnerships to Support an Entrepreneurial Ecosystem Roger Neece, President.
Arivia.kom strategy and way forward Update 20 August 2003.
CONFIDENTIAL For Internal Use Only UCI BPC Workshop ”Attributes of Successful Teams in Start-up Enterprises ” John Creelman (MBA 1989, Finance) January.
Prepared by Collaborative Economics. EXECUTIVE SUMMARY  San Diego is participating in a new global innovation economy  San Diego’s global reach has.
Michelle Howell REIF Senior Manager Scottish Enterprise.
“Managing a Startup in Turbulent Times” Satellite Broadcast Presented by Fred A. Middleton General Partner Sanderling Ventures June 6, 2001.
Charleston, SC. Charleston Digital Corridor The mission of the Charleston Digital Corridor is to attract, nurture and grow knowledge-based companies.
IT start-ups in China vs US Wu-Fu Chen Acorn Campus September 9, 2003.
Innovation The Growth Strategy Liu Bo | 刘 博. Tsinghua University Science Park Founded in 1999 , Innovation Services One of he Largest university science.
Innovate UK our offer to GM Businesses
Venture Capital Guiding Fund for Technology-based SMEs
Operational Objectives
Investor Presentation March, 2015
April 2, 2008 U.S. Listing Opportunities for Israeli Companies Presented by Guy Cohen Executive Director, Head of Israeli Investment Banking,
…. the Angel Perspective
Matt Grattan Director, Community & Economic Development University at Albany.
Executive Summary Regenerator Genetics, Inc is a genetic engineering company that intends to research, design, patent and market synthetic tissue samples.
1H 2013 Venture Capital Exits Presentation Slide Deck
The Missing Link: Role of Chambers in Private Sector Development
Austin Technology Incubator Accelerating Innovation
John K. Paglia, Ph.D., CFA, CPA
Nurturing Growth in Healthcare
Brendan Rauw, MBA, CLP Introduction
Private Equity Trends 1Q 2012 Presentation Slide Deck
East Coast Investment Overview: MAA, NE, NYMA, SE
Informal Risk Capital, Venture Capital,
Bertelsmann Education Strategy
IBA Annual Conference September 2016.
TGFS- Venture Capital Fonds for Saxony
Presentation transcript:

www.dealystrategy.com, lisa.ghezzi@dealystrategy.com The Dealy Strategy Group LLC Presentation to Health TechNet March 21, 2000 by Lisa Marie Ghezzi www.dealystrategy.com, lisa.ghezzi@dealystrategy.com The DEALY STRATEGY GROUP LLC, March 21, 2000

Venture Capital Investment Trends Increasing Funds Raised and Invested Internet-related firms receive a majority of funds Healthcare Industry related investments increase over 1998 Venture Capital increasingly important to driving economic development The DEALY STRATEGY GROUP LLC, March 21, 2000

Venture Capital Funds Raised Source: National Venture Capital Association The DEALY STRATEGY GROUP LLC, March 21, 2000

Companies Receiving Funding Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

Venture Capital Investments 1999 Total Investments 2.5 times Investments in 1998 Source: National Venture Capital Association The DEALY STRATEGY GROUP LLC, March 21, 2000

Venture Capital Financing by Industry Sector Source: National Venture Capital Association, Venture Economics * Internet Specific - companies that would not exist without the Internet and that would not fit in any other industry sector; Internet related companies are found in all industry sectors; total investment $31.9B compared to $7.0B in 1998. The DEALY STRATEGY GROUP LLC, March 21, 2000

Venture Capital Investment in Healthcare Industry Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

Venture Capital Financing by Region Every region experienced a minimum of 60% growth. Leaders: Northern California -- 215% Northwest - 210% Mid-Atlantic -- 180% Average venture size varies by region (1/99 - 9/99): Mid-Atlantic led with $13M Southern California -- exceeding $12M Northern California, NE and Rocky Mt -- $11M SW, NW, Midwest and SE -- range from $8 to $9.5M Growth in investments is indicative that the entrepreneurial communities are maturing -- supported by strong technology community, educated workforce and efficient infrastructure Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

Internet vs. Non-Internet Venture Capital Investments by Region Internet-related Venture Capital financing in the Mid-Atlantic ranked 4th with $2.2B (roughly 55%); non-Internet investments -- $1.8B, or 45%. Mid-Atlantic ranked among the highest for non-Internet-related investments. Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

VC Investment Increases Drive Economic Growth Greater number of Venture-backed companies go public in 1999 compared to earlier years -- 50% vs. 21% and 22% in 1998 and 1997 respectively. Median age of venture-backed company was 4 years compared to 4.5 years in 1998; 5 years in 1997 -- compare to 10.5 years in 1994; Internet company short life is greatly contributing to this -- in 1999, the Internet-related company was 4.3 years to IPO, vs. the Non-Internet-related company at 7.6 years. Increasing number of IPOs allows for quicker liquidity and reinvestment into new opportunities. Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

Average Offering and Valuation of Venture-backed Companies Increasing Average offering size was 77% greater than in 1998 Average post offer valuation was over 2x that of 1998 Note: numbers may be slightly off due to rounding Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

Top Venture Capital Firms Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

Top Venture Capital Firms Investing in Healthcare/Medical/Biotech Chase Hambrecht & Quist primary venture investing vehicle is Access Technology Partners, L.P., $330M fund health/bio: biotechnology, bio-informatics, pharmaceuticals, medical devices, and drug delivery, and information, management, and outsourcing services The DEALY STRATEGY GROUP LLC, March 21, 2000

Top Venture Capital Firms Investing in Healthcare/Medical/Biotech New Enterprise Associates investment focus: medical and life sciences -- biotechnology, pharmaceuticals, healthcare services, medical devices, instrumentation and information management stage: principally in early stage companies Three Primary questions asked: Will the company change the way people behave, via a unique product or service? Is there an unbounded opportunity, reflected by a large potential market, manageable competition and reasonable capital requirements? Is there a quality management team with experience and breadth? Are they people NEA can work with "through thick and thin" - especially thin? The DEALY STRATEGY GROUP LLC, March 21, 2000

Top Venture Capital Firms Investing in Healthcare/Medical/Biotech Sequoia investment focus: biotechnology, medical devices, services (primarily B2B), software instrumentation and information management) makes 8 to 10 investments each year along with 12 to 15 follow-on investments stage: very early stages investing partners include: Kleiner, Perkins, Caulfield & Byers The DEALY STRATEGY GROUP LLC, March 21, 2000

Top Venture Capital Firms Investing in Healthcare/Medical/Biotech Kleiner, Perkins, Caulfield & Byers investment focus: life sciences -- medical devices and diagnostics, drug discoveries and therapeutics, health care services and informatics investing partners include: Sequoia, Weiss Peck & Greer Venture Partners corporate partners through JAVA fund “Keiretsu” approach -- shared information and knowledge, network of 175 companies and 1000s executives The DEALY STRATEGY GROUP LLC, March 21, 2000

Top Venture Capital Firms Investing in Healthcare/Medical/Biotech Integral Partners: investment focus: life sciences sector -- emerging medical technologies and health care information systems; diseases -- particularly active with companies targeting the cardiology and oncology markets. stage: expansion-stage private and growth-stage public investing partners include: Kleiner, Perkins, Caulfield & Byers, Silver Lake Partners The DEALY STRATEGY GROUP LLC, March 21, 2000